593 results on '"Fukushi, Shuetsu"'
Search Results
2. Macacine alphaherpesvirus 1 (B Virus) Infection in Humans, Japan, 2019
3. Structural delineation and computational design of SARS-CoV-2-neutralizing antibodies against Omicron subvariants
4. Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates
5. Heterologous SARS-CoV-2 spike protein booster elicits durable and broad antibody responses against the receptor-binding domain
6. Pathological and virological findings of type I interferon receptor knockout mice upon experimental infection with Heartland virus
7. Antiviral efficacy against and replicative fitness of an XBB.1.9.1 clinical isolate
8. Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents
9. Saturation time of exposure interval for cross-neutralization response to SARS-CoV-2: Implications for vaccine dose interval
10. Non-Omicron breakthrough infection with higher viral load and longer vaccination-infection interval improves SARS-CoV-2 BA.4/5 neutralization
11. Development of a vesicular stomatitis virus pseudotyped with herpes B virus glycoproteins and its application in a neutralizing antibody detection assay
12. Characterization of a new SARS-CoV-2 variant that emerged in Brazil
13. Safety and immunogenicity of the Pfizer/BioNTech SARS-CoV-2 mRNA third booster vaccine dose against the BA.1 and BA.2 Omicron variants
14. Essential role of TMPRSS2 in SARS-CoV-2 infection in murine airways
15. Formation and Long-Term Culture of hiPSC-Derived Sensory Nerve Organoids Using Microfluidic Devices.
16. Characterization of Keterah orthonairovirus and evaluation of therapeutic candidates against Keterah orthonairovirus infectious disease
17. Successful treatment of acyclovir‐resistant herpes simplex virus infection with amenamevir in a patient who received umbilical cord blood transplantation for T‐cell prolymphocytic leukemia
18. Mice, myeloid cells, and dengue: a new model for unraveling vascular leakage mysteries
19. Reston Ebolavirus in Macaques
20. Seroprevalence and Risk Factors of Severe Fever with Thrombocytopenia Syndrome : Seroepidemiology of SFTS
21. Inactivation of severe fever with thrombocytopenia syndrome virus for improved laboratory safety
22. Inactivation of SARS-CoV-2 in serum using physical methods
23. Lethal severe fever with thrombocytopenia syndrome virus infection causes systemic germinal centre failure and massive T cell apoptosis in cats
24. Construction of a recombinant vaccine expressing Nipah virus glycoprotein using the replicative and highly attenuated vaccinia virus strain LC16m8
25. Dengue virus infection induces selective expansion of Vγ4 and Vγ6TCR γδ T cells in the small intestine and a cytokine storm driving vascular leakage in mice
26. Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein
27. Purification of Crimean–Congo hemorrhagic fever virus nucleoprotein and its utility for serological diagnosis
28. Prevalence of Antibodies to Crimean-Congo Hemorrhagic Fever Virus in Ruminants, Nigeria, 2015
29. Severe fever with thrombocytopenia syndrome virus targets B cells in lethal human infections
30. Competitive ELISA for the Detection of Serum Antibodies Specific for Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
31. Seroprevalence of severe fever with thrombocytopenia syndrome (SFTS) virus antibodies in humans and animals in Ehime prefecture, Japan, an endemic region of SFTS
32. Characterization of novel monoclonal antibodies against the MERS-coronavirus spike protein and their application in species-independent antibody detection by competitive ELISA
33. A neutralization assay with a severe fever with thrombocytopenia syndrome virus strain that makes plaques in inoculated cells
34. Retrospective survey of severe fever with thrombocytopenia syndrome in patients with suspected rickettsiosis in Japan
35. Seroprevalence of Jamestown Canyon virus in the Japanese general population
36. Effective inactivation of Nipah virus in serum samples for safe processing in low-containment laboratories
37. Association of human cytomegalovirus (HCMV) neutralizing antibodies with antibodies to the HCMV glycoprotein complexes
38. Specific COVID-19 risk behaviors and the preventive effect of personal protective equipment among healthcare workers in Japan
39. Estimating serum cross-neutralizing responses to SARS-CoV-2 Omicron sub-lineages elicited by pre-Omicron or Omicron breakthrough infection with exposure interval compensation modeling
40. Severe Fever with Thrombocytopenia Syndrome Phlebovirus causes lethal viral hemorrhagic fever in cats
41. Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters
42. Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB
43. Successful Treatment with Letermovir in a Heart Transplant Recipient with UL97 Mutation Ganciclovir-Resistant Cytomegalovirus Colitis and Viremia
44. Simple and rapid detection of severe fever with thrombocytopenia syndrome virus in cats by reverse transcription-loop-mediated isothermal amplification (RT-LAMP) assay using a dried reagent
45. Corrigendum: An in Vitro Short-Term Treatment with Black Tea-Derived Theaflavins Reduced Infectivity of SARS-CoV-2 in Saliva
46. Structural delineation of SARS-CoV-2 broadly neutralizing antibody to Omicron subvariants including BA.4/BA.5 and BA.2.75
47. Varicella Vaccine-Induced Infantile Zoster-Like Skin Rash
48. First isolation and characterization of pteropine orthoreoviruses in fruit bats in the Philippines
49. Phylogenetic and Geographic Relationships of Severe Fever With Thrombocytopenia Syndrome Virus in China, South Korea, and Japan
50. Longitudinal Trends of Prevalence of Neutralizing Antibody against Human Cytomegalovirus over the Past 30 Years in Japanese Women
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.